Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BETH ISRAEL DEACONESS MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1896-01-01

Employees: -

Market Cap: -

Website: https://www.bidmc.org/

Clinical Trials

Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders

Completed

Conditions: Myopathies
Parkinson's Disease
Myasthenia Gravis
Amyotrophic Lateral Sclerosis (ALS)
Stroke

First Posted Date: 2014-04-21

Last Posted Date: 2024-04-16

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 100

Registration Number: NCT02118805

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Biomechanics of Metastatic Defects in Bone

Active, not recruiting

Conditions: Cancer Bone
Bone Tumors

First Posted Date: 2014-04-10

Last Posted Date: 2024-05-09

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 245

Registration Number: NCT02109952

Locations: 🇺🇸
Alvin and Lois Lapidus Cancer Center, Sinai Hospital of Baltimore, Inc, Baltimore, Maryland, United States
🇺🇸
Department of Orthopaedic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States
🇺🇸
Department of Orthopaedic Surgery, University of Minnesota Medical Center, Minneapolis, Minnesota, United States

and more 5 locations

Innovative Ultrasound Technology in Neuromuscular Disease

Completed

Conditions: Amyotrophic Lateral Sclerosis
Radiculopathy
Myopathy
Muscular Dystrophy
Polyneuropathy and Mononeuropathies
Trauma Injury
Orthopedic Disorder

First Posted Date: 2014-04-07

Last Posted Date: 2022-03-11

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 223

Registration Number: NCT02104921

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Statin Therapy in Acute Influenza

Phase 2

Completed

Conditions: Influenza

Interventions: Drug: Placebo
Drug: Atorvastatin

First Posted Date: 2014-02-06

Last Posted Date: 2019-07-26

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 116

Registration Number: NCT02056340

Locations: 🇺🇸
The Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

JC Virus Reactivation in Multiple Sclerosis

Completed

Conditions: Progressive Multifocal Leukoencephalopathy
Multiple Sclerosis

First Posted Date: 2013-12-09

Last Posted Date: 2016-01-29

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 50

Registration Number: NCT02004444

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Tai Chi After Pulmonary Rehabilitation in Patients With COPD: A Randomized Trial

Not Applicable

Completed

Conditions: Chronic Obstructive Pulmonary Disease (COPD)

Interventions: Behavioral: Tai Chi
Behavioral: Group Walking

First Posted Date: 2013-12-02

Last Posted Date: 2018-10-03

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 90

Registration Number: NCT01998724

Locations: 🇺🇸
VA Healthcare System, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

The Effect of Thiamine vs. Placebo on VO2 in Critical Illness

Phase 2

Completed

Conditions: Critically Ill
Respiratory Failure

Interventions: Drug: Thiamine

First Posted Date: 2013-11-15

Last Posted Date: 2017-10-02

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 66

Registration Number: NCT01985685

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

The Effects of DHA on Periodontitis

Phase 2

Completed

Conditions: Gingivitis
Inflammation
Periodontitis

Interventions: Drug: Aspirin
Drug: Docosahexaenoic acid
Drug: Placebo (for Docosahexaenoic acid)

First Posted Date: 2013-11-06

Last Posted Date: 2017-12-13

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 55

Registration Number: NCT01976806

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Transcranial Magnetic Stimulation in Spino-Cerebellar Ataxia

Not Applicable

Completed

Conditions: Spinocerebellar Ataxia

Interventions: Device: Transcranial Magnetic Stimulation

First Posted Date: 2013-11-05

Last Posted Date: 2017-05-30

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 20

Registration Number: NCT01975909

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

The Effect of Linagliptin on Mitochondrial and Endothelial Function

Phase 4

Completed

Conditions: Type II Diabetes Mellitus

Interventions: Drug: Placebo
Drug: Linagliptin
Other: Microcirculation testing
Other: Macrocirculation testing
Other: MRI Scans

First Posted Date: 2013-10-25

Last Posted Date: 2016-11-18

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 45

Registration Number: NCT01969084

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy